A 2019 symposium at the American Orthotic and Prosthetic Association National Assembly highlighted the leading multiarticulating hands available in the US marketplace. Össur’s i-Limb hand, TASKA’s Gen2 hand, and Ottobock’s bebionic hand were featured as the leading players. Other hands mentioned but not reviewed, either because there was no formal US distribution or they were recently launched and there was not enough information available to fairly compare them, were the Vincent Hand, Hy5’s hydraulic MyHand, COVVI’s Nexus hand, Psyonic’s Ability Hand, Mobius Bionics’ LUKE hand, and Open Bionics’ Hero Arm.
Fast forward to 2024 and new multiarticulating hand players are entering the US market, such as COVVI’s Hand, Aether Medical’s Zeus Hand, and BionIT Labs’ Adams Hand. Manufacturers such as BrainRobotics, Esper, Rebel Bionics, and Prensilia are knocking at the door, while a few other upstart companies have vanished from the market.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
